The probiotic mixture administered to mice with colitis reduced the frequencies of CD40+ (p < 0.001), CD83+ (p < 0.01), and CD80+ (p < 0.001) cells compared to untreated colitis mice (Figure 4A–C). This evidence concerns the gene CD83 and colitis.